provo semaglutide Focus: Demand for weight-loss drugs fuels global rise in counterfeits ProMD Health: Weight Management Programs

Semaglutide, marketed under brand names including Ozempic, Wegovy, and Rybelsus, is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management

Because semaglutide decreases appetite, eating nutrient dense foods while on it is important to ensure each calorie you consume is contributing to nutritional requirements for protein, fiber, vitamins, and minerals

Solorzano C, Ehrmann D, Azziz R

In 2023, Ozempic sales reached nearly $14 billion

However, injecting it the right way is key to seeing these benefits

Type 2 diabetes specific considerations Individuals with type 2 diabetes starting tirzepatide often require adjustments to their existing diabetes medications